ライフサイエンスコーパス: anesthetic agent

1 y secretions that could be attributed to the anesthetic agent.

2 s a powerful anxiolytic, anticonvulsant, and anesthetic agent.

3 t that was developed over 50 years ago as an anesthetic agent.

4 endent on a known interaction site for local anesthetic agents.

5 sm, which alter the pharmacokinetics of many anesthetic agents.

6 losporine A, radiocontrast dyes and volatile anesthetic agents.

7 imental evidence supports neuroprotection by anesthetic agents.

8 ro- and anti-convulsant effects of the newer anesthetic agents.

9 as performed to compare ketamine and 7 other anesthetic agents.

10 Volatile anesthetic agent, 1-chloro-1,2,2-trifluorocyclobutane (F

11 and enflurane, three commonly used volatile anesthetic agents, affect glutamate receptor-modulated n

12 ve considerable potential to be developed as anesthetic agents and as drugs to treat brain disorders

13 r any of the commonly available inhalational anesthetic agents and each can be used for general anest

14 associated with the use of lower amounts of anesthetic agents and faster recovery from anesthesia in

15 e cells, and are molecular targets for local anesthetic agents and intracellular free Ca(2+) ([Ca(2+)

16 1 measurements obtained with several inhaled anesthetic agents and propofol dissolved in saline were

17 ciousness level, consistent across different anesthetic agents and sleep.

18 Advances in anesthetic agents and techniques for interventional pulm

19 ystem development and are being developed as anesthetic agents and treatments for psychiatric disease

20 he level of consciousness in volunteers with anesthetic agents and visualizing the resultant changes

21 Epidemiological studies suggest exposures to anesthetic agents and/or sedative drugs (AASDs) in child

22 All exposed children received inhaled anesthetic agents, and anesthesia duration ranged from 2

23 story of corneal surgery, allergy to topical anesthetic agents, and current eye infection.

24 idence for neuroprotective effects of common anesthetic agents, and presents potential mechanisms inv

25 mparison to other small hydrophobic poisons, anesthetic agents, and protein toxins that inhibit ion c

26 ECT intervention with ketamine and/or other anesthetic agents; and (3) measures included: depressive

27 Mechanisms of neuroprotection by anesthetic agents appear to involve suppression of excit

28 Gaseous anesthetic agents are among the most potent drugs that c

29 Intravenous anesthetic agents are associated with cardiovascular ins

30 channels, which are putative targets for the anesthetic agents, as well as advancements in high-perfo

31 visiae was used to investigate the action of anesthetic agents because of its powerful molecular gene

32 rcotics, antipsychotics, inotropes, digoxin, anesthetic agents, bronchodilators, and drugs that cause

33 corporating standard monitoring of end-tidal anesthetic-agent concentration (ETAC) for the prevention

34 esthetic management directed by an end-tidal anesthetic-agent concentration protocol is equally effec

35 uch higher (toxic) concentrations of certain anesthetic agents did alter lipid bilayer properties.

36 Although it is widely held that anesthetic agents disrupt the processes regulating LH re

37 ty of surgical wound infiltration with local anesthetic agents during cesarean delivery for the reduc

38 y benefit from neuroprotective properties of anesthetic agents during surgery.

39 lness, escalating and constant levels of two anesthetic agents (experiment 1, n = 39), and during sle

40 he same surgical preparation and sequence of anesthetic agent exposure but no brain insult.

41 ed mutation at an interaction site for local anesthetic agents (F1760A) partially attenuated the effe

42 Isoflurane, a volatile anesthetic agent, has been recognized for its potential

43 Inhalational anesthetic agents have also been shown to result in brai

44 It is less widely known that several other anesthetic agents have also shown antidepressant effects

45 Anesthetic agents have been shown to have a profound eff

46 All currently used general anesthetic agents have either NMDA receptor-blocking or

47 Furthermore, because anesthetic agents have the unique ability to reversibly

48 Ca(2+), changes in internal and external pH, anesthetic agents, heat, stretch and membrane deformers.

49 the pharmacokinetics and pharmacodynamics of anesthetic agents in the obese population, we specify ce

50 or measuring the hydrophobicity of the local anesthetic agents in the unionized form.

51 The use of anesthetic agents, including propofol, have been adminis

52 nderstanding how illicit drugs interact with anesthetic agents is of paramount importance.

53 that anesthetic management and even specific anesthetic agents may worsen outcomes in high-risk patie

54 Halogenated inhaled general anesthetic agents modulate voltage-gated ion channels, b

55 a method for studying the interaction of two anesthetic agents, Morphine and Midazolam, acting simult

56 inhaled volatile (isoflurane or sevoflurane) anesthetic agent (n = 67).

57 ting or motion sickness, young age, volatile anesthetic agents, nitrous oxide, and the administration

58 sics, benzodiazepines, opioids, inhalational anesthetic agents, nitrous oxide, ketamine, barbiturates

59 trate clear-cut superiority for any specific anesthetic agent or approach.

60 ion mucociliary transportability with either anesthetic agent or with atropine.

61 tudies that would support the use of any one anesthetic agent over the others.

62 evaluation of patients, discovery of better anesthetic agents, pain control, and the evolution of pe

63 on the precise mechanisms by which hypnotic anesthetic agents produce their effects.

64 The anesthetic agent propofol (2,6-diisopropylphenol) is the

65 We used functional MRI and the anesthetic agent propofol to assess the relationship amo

66 Here, we used the anesthetic agent, propofol, to modulate consciousness an

67 Here we show that two GABAmimetic anesthetic agents--propofol and sodium thiopental--prote

68 Many general anesthetic agents regulate voltage-gated Na(+) (NaV) cha

69 s of initiating brexanolone infusion without anesthetic agent reinstatement in the following 24 hours

70 cological postconditioning with the volatile anesthetic agent sevoflurane (n = 48), intermittent clam

71 Anesthetic agents should be considered based on patient

72 Three other volatile anesthetic agents show a similar pattern.

73 pport a neuroprotective potential of several anesthetic agents, specifically isoflurane and xenon, co

74 erefore, we propose that amphiphilic general anesthetic agents such as 1-alkanols may modulate gating

75 Propofol is a sedative and anesthetic agent that can both activate GABA(A) receptor

76 Anesthetic agents that do not interfere with auditory fu

77 Other studies have shown that titrating anesthetic agents to a specific bispectral index value d

78 uring surgery and also to optimize dosing of anesthetic agents to maximize the desired/undesired effe

79 nificant correlation between the duration of anesthetic agent use and DeltaVBR was found (Spearman r

80 Volatile anesthetic agent use in the intensive care unit, aided b

81 s, perhaps because of confounding effects of anesthetic agents used in most animal experiments on fun

82 Exposure to all episodes of anesthetic agents was abstracted.

83 esized, and the utility of these steroids as anesthetic agents was evaluated through determination of

84 Anesthetic agents were required for a median of 13 (IQR,

85 Anesthetic agents were used in 55 episodes (87.30%), and

86 Xenon and dichloromethane are inhalational anesthetic agents whose binding to myoglobin has been de

87 Propofol is a widely used intravenous anesthetic agent with antioxidant properties.

88 EG parameters to increasing concentration of anesthetic agents with a dosing plateau response over a

89 models determined associations of cumulative anesthetic agents with the primary neurocognitive outcom

90 udies could examine the use of longer-acting anesthetic agents with ultrasonography-guided BRSB.

91 lum can be targeted with US for injection of anesthetic agents, with adequate spread of injected meth

92 001) and receipt of intravenous propofol, an anesthetic agent without preservative, which was adminis